- CEO
- Emmanuel Rupert
- Full Time Employees
- 15,467
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- 261/A, Bommasandra Industrial Area Bangalore KA India 560099
- IPO Date
- Jan 6, 2016
- Business
- Narayana Hrudayalaya Limited operates as a leading healthcare service provider in India and internationally, specializing in multispecialty and super-specialty hospital networks. Its core products and services encompass cardiac surgery and cardiology; diabetes and endocrinology; gastroenterology; nephrology; neurology; orthopedics; oncology; pulmonology; critical care; imaging and diagnostics; and outpatient and inpatient care through its hospital chain. The company manages a comprehensive portfolio of healthcare facilities, including tertiary care hospitals, specialty clinics, diagnostic laboratories, and health insurance products. Narayana Hrudayalaya operates extensively across major Indian cities such as Bangalore, Delhi, Mumbai, Kolkata, Gurugram, and Ahmedabad, and internationally through its Health City Cayman Islands subsidiary. Founded in 2000 and headquartered in Bangalore, the company is recognized for offering affordable yet advanced medical care through a scalable model.
In recent developments, Narayana Hrudayalaya has significantly expanded its global footprint with the acquisition of UK-based Practice Plus Group Hospitals for approximately Rs 2200 crore, marking a strategic move into the European healthcare market. Additionally, the company launched innovative health insurance products in 2024, including 'Aditi' and 'Arya,' targeting insurance complexities and immediate coverage needs. It continues expanding its hospital infrastructure in India, with plans for a 1000-bed advanced specialty hospital in Kolkata and new hospital openings scheduled. Narayana Health has also achieved key accreditations like CAP for its laboratory services, underscoring its commitment to quality and international standards. These strategic expansions and product diversifications align with its vision to broaden access to affordable, high-quality healthcare across geographies and customer segments. The company is publicly listed on NSE and BSE and led by Group CEO Emmanuel Rupert as of January 2019.